Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  13,766 results for ""Multiple Myeloma""

Your Filters

Subject : antineoplastic agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Acquired Bortezomib Resistance in Multiple Myeloma: From Mechanisms to Strategy.

  • Authors : Li F; Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.; Liu J

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/mortality ; Bortezomib*/Bortezomib*/Bortezomib*/therapeutic use

  • Source: Current treatment options in oncology [Curr Treat Options Oncol] 2024 Nov; Vol. 25 (11), pp. 1354-1365. Date of Electronic Publication: 2024 Oct 21.Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells.

  • Authors : Wang H; Department of Medicine, University of Washington, Seattle, WA, USA.; Koob T

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2314322. Date of Electronic Publication: 2024 Feb 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Discovery of novel 20S proteasome subunit β5 PROTAC degraders as potential therapeutics for pharyngeal carcinoma and Bortezomib-resistant multiple myeloma.

  • Authors : Wang S; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.; Li Z

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 Dec; Vol. 153, pp. 107801. Date of Electronic Publication: 2024 Sep 03.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Recent advances in targeted drug delivery systems for multiple myeloma.

  • Authors : Pant A; Department of Pharmaceutical Sciences, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, 505 S 45 St, Omaha, NE 68198, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, 505 S 45 St, Omaha, NE 68198, USA. Electronic address: .

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Drug Delivery Systems* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/administration & dosage

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Dec; Vol. 376, pp. 215-230. Date of Electronic Publication: 2024 Oct 12.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Recent advancements in nanomedicine as a revolutionary approach to treating multiple myeloma.

  • Authors : Shafiei FS; Department Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran; Department of Biotechnology, Iranian Research Organization for Science & Technology (IROST), Tehran, Iran.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Nanomedicine*/Nanomedicine*/Nanomedicine*/methods ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Life sciences [Life Sci] 2024 Nov 01; Vol. 356, pp. 122989. Date of Electronic Publication: 2024 Aug 27.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Discovery of CZL-046 with an ( S )-3-Fluoropyrrolidin-2-one Scaffold as a p300 Bromodomain Inhibitor for the Treatment of Multiple Myeloma.

  • Authors : Chen Z; Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China.; Yang H

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/metabolism ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology

  • Source: Journal of medicinal chemistry [J Med Chem] 2024 Oct 24; Vol. 67 (20), pp. 18606-18628. Date of Electronic Publication: 2024 Oct 02.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma.

  • Authors : Li X; State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, Xinjiang, China; State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry

  • Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Sep 01; Vol. 111, pp. 117843. Date of Electronic Publication: 2024 Jul 22.Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bortezomib-induced neuropathy in multiple myeloma manifesting as foot drop due to peroneal nerve palsy.

Subjects: Bortezomib*/Bortezomib*/Bortezomib*/adverse effects ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/complications

  • Source: BMJ case reports [BMJ Case Rep] 2024 Sep 30; Vol. 17 (9). Date of Electronic Publication: 2024 Sep 30.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X

Record details

Read More Add to Saved list
×
Academic Journal

Discovery of Novel SIRT3 Inhibitors for the Cancer Differentiation Therapy by Structural Modification.

  • Authors : Li H; School of Chemistry and Chemical Engineering, Shandong University of Technology, Zibo, Shandong, China.; Du Y

Subjects: Sirtuin 3*/Sirtuin 3*/Sirtuin 3*/antagonists & inhibitors ; Sirtuin 3*/Sirtuin 3*/Sirtuin 3*/metabolism ; Cell Differentiation*/Cell Differentiation*/Cell Differentiation*/drug effects

  • Source: Drug development research [Drug Dev Res] 2024 Nov; Vol. 85 (7), pp. e70016.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299

Record details

Read More Add to Saved list
×
Academic Journal

Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.

  • Authors : Yang J; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu, 210023, China.; Yu YC

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116435. Date of Electronic Publication: 2024 Apr 20.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  13,766 results for ""Multiple Myeloma""